mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |